Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
4.40
Ask:
4.525
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Major Industry Awards Win

10 Apr 2006 09:19

Seeing Machines Limited10 April 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") Monday 10 April 2006 Seeing Machines Wins Major Industry Awards for Glaucoma Project Seeing Machines (AIM:SEE) was awarded two iAwards at the AIIA's galapresentation dinner last Friday night (7 April) for its glaucoma diagnosticdevice development. • The "Local Industry Award" - for the most innovative ICT project undertaken by an Australian local industry company (small-to-medium enterprise), and • The "Research and Development Award" - for the most outstanding ICT R& D project The iAwards, Australia's premier industry awards for the Information andCommunications Technology (ICT) sector, are awarded by the AustralianInformation Industry Association (AIIA) for outstanding ICT solutions across 15categories from Agriculture & Primary Industries, e-Government & Service,Research & Development through to Tourism & Hospitality. In addition there arefive major awards: the Local Industry Award, Community Award, InnovativeCommercial Software Award, the Inspiration Award and the CSIRO Tony BensonAward. Seeing Machines won the iAward for the Research and Development category, andthen also picked up the major Local Industry Award for the most innovative ICTproject undertaken by an Australian SME. Seeing Machines is developing the world's first non-contact objective device fordiagnosing glaucoma and a range of other eye diseases, utilising itsmarket-leading, patent-protected computer vision technology. These nationalawards recognize the progress that has been made to date in this project and thesignificant commercial opportunity arising from the pioneering work of theSeeing Machines team and its colleagues at the Research School of BiologicalSciences at the Australian National University. Seeing Machines would like tothank the AIIA for its recognition of this important work. The full list of iAwards is available at: www.aiia.com.au/i-cms.isp?page=1290. -- ends -- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com About the AIIA and the iAwards Details about the Australian Information Industry Association (AIIA) areavailable here: www.aiia.com.au/i-cms.isp?page=13 Details about the iAwards are available here: www.aiia.com.au/i-cms.isp?page=243. About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on visionbased human machine interfaces. Formed in 2000 in Canberra, Australia, SeeingMachines' purpose is to commercialise its computer-vision across a range ofindustries and applications. Seeing Machines deliver advanced computer vision solutions for researches anddeveloper in human factors, transportation safety, computer human interaction,robotics, medical research and psychology. The flagship product faceLABTMprovides an automated and contact-free gaze and head tracking technology, itsolves the problem of observing human behaviour naturally, non-intrusively andwith a high degree of accuracy and usability. faceLABTM is a computer vision system that is able to measure the orientationand position of a human head, as well as detect blinks and estimategaze-direction. It achieves all of this completely visually through a stereocamera system connected to advanced image processing software, with noattachments required on the subject. The product is designed to allow humanfactors researchers and designers assess the interaction of an operator in anenvironment and this finds application in designing operator environments, suchas cockpits for cars, trucks, trains, and aeroplanes for instance, and otherindustrial design applications, as well as medical and psychological researchsituations. The technology also has application in monitoring automobiledrivers and if it detects drowsiness or that the driver is distracted and theirattention has been diverted from the road, an alarm can be raised to alert thedriver to either pull over and rest in the case of drowsiness or to pay moreattention to the road. faceLABTM works in real-time, enabling the behaviour of a subject to be tracked.This technology is paving the way in promoting safer driving conditions andworks to enhance the driving experience and to eliminate accidents causedthrough driver drowsiness or distraction. There are many different sectors that can benefit from this revolutionarysoftware, for which it has been developed, including: automotive; academicresearch; medicine/healthcare; defence; autostereoscopy (next generationdisplays); sport; and games. Seeing Machines is currently working with researchers from the Research Schoolof Biological Sciences at the Australian National University to enable a newobjective method for diagnosing and managing glaucoma, a leading source ofblindness. This technology could complement or replace existing visual fieldtesting devices used by more than 70,000 ophthalmologists globally and may haveapplication in detecting other eye and neurological diseases. Seeing Machinesis developing a technology based on a completely objective method that uses aninvoluntary physiological response. This has the potential to become a 'goldstandard' in the diagnosis and management of glaucoma to derive reliable,repeatable results and greater diagnostic accuracy. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.